carmethizole has been researched along with Leukemia L 1210 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, WK; Dykes, DJ; Griswold, DP; Harrison, SD; Plowman, J; Waud, WR | 1 |
| Anderson, WK; Elliott, WL; Fry, DW; Hawkins, PA; Hook, KE; Leopold, WR; Nelson, JM | 1 |
2 other study(ies) available for carmethizole and Leukemia L 1210
| Article | Year |
|---|---|
Antitumor activity and cross-resistance of carmethizole hydrochloride in preclinical models in mice.
Topics: Animals; Antineoplastic Agents; Carcinoma, Small Cell; Drug Evaluation, Preclinical; Drug Resistance; Humans; Imidazoles; Leukemia L1210; Leukemia P388; Lung Neoplasms; Mammary Neoplasms, Experimental; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Transplantation, Heterologous | 1992 |
In vivo and in vitro evaluation of the alkylating agent carmethizole.
Topics: Animals; Antineoplastic Agents; Carmustine; DNA Repair; DNA, Neoplasm; Drug Screening Assays, Antitumor; Imidazoles; Leukemia L1210; Leukemia P388; Melphalan; Tumor Cells, Cultured | 1991 |